An analysis of the attrition of drug candidates from four major pharmaceutical companiesMichael J. Waring, Alex. M. Weir, John Arrowsmith et al.|Nature Reviews Drug Discovery|2015Cited by 1.4k
Target-Based Evaluation of “Drug-Like” Properties and Ligand EfficienciesPaul D. Leeson, Andrew R. Leach, A. Patrícia Bento et al.|Journal of Medicinal Chemistry|2021Cited by 143
Occurrence of “Natural Selection” in Successful Small Molecule Drug DiscoveryAnna Lina Heinzke, Paul D. Leeson, Robert J. Young et al.|Journal of Medicinal Chemistry|2024Cited by 20
Pseudonatural Products for Chemical Biology and Drug DiscoveryLuca C. Greiner, Herbert Waldmann, Axel Pahl et al.|Journal of Medicinal Chemistry|2025Cited by 15
A compound-target pairs dataset: differences between drugs, clinical candidates and other bioactive compoundsAnna Lina Heinzke, Andrew R. Leach, Barbara Zdrazil et al.|Scientific Data|2024Cited by 8